Roundview Capital LLC - THERAVANCE INC ownership

THERAVANCE INC's ticker is THRX and the CUSIP is 88338T104. A total of 145 filers reported holding THERAVANCE INC in Q1 2014. The put-call ratio across all filers is 0.93 and the average weighting 0.4%.

Quarter-by-quarter ownership
Roundview Capital LLC ownership history of THERAVANCE INC
ValueSharesWeighting
Q4 2015$1,046,000
-30.7%
99,235
-52.8%
0.41%
-36.0%
Q3 2015$1,509,000
-60.3%
210,186
-0.2%
0.65%
-54.8%
Q2 2015$3,805,000
+2.9%
210,586
-10.4%
1.43%
-2.0%
Q1 2015$3,696,000
+17.9%
235,106
+6.1%
1.46%
+13.7%
Q4 2014$3,134,000
+30.9%
221,507
+58.1%
1.29%
+19.4%
Q3 2014$2,395,000
-42.8%
140,145
-0.4%
1.08%
-36.4%
Q2 2014$4,188,000
+380.8%
140,645
+399.6%
1.69%
+300.2%
Q1 2014$871,000
-12.9%
28,150
+0.4%
0.42%
-7.6%
Q4 2013$1,000,00028,0500.46%
Other shareholders
THERAVANCE INC shareholders Q1 2014
NameSharesValueWeighting ↓
Baupost Group 20,395,056$607,365,0009.89%
Realm Partners LLC 301,521$8,979,0003.75%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 2,805,837$83,558,0002.52%
IRIDIAN ASSET MANAGEMENT LLC/CT 7,447,743$221,794,0002.27%
SECTORAL ASSET MANAGEMENT INC 1,743,188$51,912,0002.20%
Foundation Asset Management, LP 255,790$7,617,0002.19%
Proxima Capital Management, LLC 550,000$16,379,0001.93%
Roundview Capital LLC 140,645$4,188,0001.69%
BB BIOTECH AG 933,244$27,792,0001.32%
PERRY CAPITAL 1,517,208$45,182,0001.25%
View complete list of THERAVANCE INC shareholders